Physician profile
Robert Ezeibekwe Nwosu
NPI 1558756957
$3,528.96
in general payments reported to CMS, 2019-2025
7 companies · $76.08 in 2025
The $76.08 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2021: $1,200 · 2022: $1,235 · 2023: $32.55 · 2024: $284 · 2025: $76.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $392.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $3,082.00 | 2019-2022 | |
| Smith+Nephew, INC. | $203.63 | 2022-2024 | Collagenase Santyl, Versajet, Renasys Go V2 Home |
| Treace Medical Concepts, INC. | $120.46 | 2024 | |
| Organogenesis INC. | $62.50 | 2025 | Via Matrix, Apligraf, Cygnus Dual |
| Nevro Corp. | $27.05 | 2022-2024 | Senza |
| Stryker Corporation | $19.74 | 2019 | |
| Amgen INC. | $13.58 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Nwosu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.